Role of calprotectin in cardiometabolic diseases

Peter Kruzliak1, Jan Novák2, Miroslav Novák3

  • 1Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne' University Hospital Brno, Brno, Czech Republic; Institute of Normal and Pathological Physiology and Centre of Excellence for Regulatory Role of Nitric Oxide in Civilisation Diseases, Slovak Academy of Sciences, Bratislava, Slovak Republic.

Insights

Calprotectin, a marker of inflammation, shows promise as a prognostic factor for cardiovascular and cardiometabolic diseases. This peptide may help predict the progression of atherosclerosis and related conditions.

Area of Science:

  • Biochemistry
  • Immunology
  • Cardiology

Background:

  • Calprotectin is a peptide secreted by neutrophils and monocytes during inflammation.
  • It is a known biomarker for inflammatory bowel diseases.
  • Cardiovascular and cardiometabolic diseases are linked to low-grade chronic inflammation.

Purpose of the Study:

  • To review the role of calprotectin in cardiometabolic risk.
  • To explore calprotectin's potential as a prognostic factor for cardiovascular diseases.
  • To highlight calprotectin's utility in diagnosing and stratifying risk for cardiometabolic conditions.

Main Methods:

  • Literature review of studies on calprotectin and inflammation.
  • Analysis of research linking calprotectin to cardiovascular and cardiometabolic diseases.
  • Synthesis of evidence regarding calprotectin's diagnostic and prognostic value.

Main Results:

  • Calprotectin is involved in inflammatory processes.
  • Emerging evidence suggests calprotectin as a prognostic marker for cardiovascular diseases.
  • Calprotectin may predict the course of atherosclerosis, coronary artery disease, and acute coronary syndromes.

Conclusions:

  • Calprotectin's role extends beyond inflammatory bowel diseases.
  • It holds significant potential as a prognostic biomarker for cardiometabolic risk.
  • Further research is warranted to fully establish calprotectin's clinical utility in cardiology.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
973
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
35
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
34
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K